CARROLL DAVID FRANCIS (SVP, CFO and Treasurer) sold 48.1% of their position (63.50K shares) of IVERIC BIO, INC. on the open market
Open‑market sale worth $2.35M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/3/2023ACC: 0001410939-23-000060
Officer· SVP, CFO and Treasurer
Since Jul 2018
-63.50K
Net shares
Net seller
$2.35M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
63.50K acquired · 127K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+63.50K
Price / share
$2.81
Trade value
$178.44K
% of position
92.7%
5/1/2023
68.47K→131.97K
Common Stock
Direct
Shares
−63.50K
Price / share
$37.04
Trade value
$2.35M
% of position
48.1%
5/1/2023
131.97K→68.47K
Total
Net shares
+0.00
Net value
-$2.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2023 | M · Option Exercise | +63.50K | $2.81 | $178.44K | 92.7% | 68.47K | 131.97K |
| Common Stock Direct | 5/1/2023 | S · Sale | −63.50K | $37.04 | $2.35M | 48.1% | 131.97K | 68.47K |
| Total | +0.00 | -$2.17M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
63.50K shares
Shares
−63.50K
Strike price
2.81
Held after
0.00
Exercisable
—
5/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock63.50K shares | 5/1/2023 | M · Option Exercise | −63.50K | 2.81 | — | 0.00 |